Biopharma News

Oct 15, 2014
By BioPharm International Editors
AbbVie sends Shire notice that it is reconsidering its offer recommendation.
Oct 09, 2014
By BioPharm International Editors
FDA granted Genentech priority review for its diabetic retinopathy treatment, Lucentis.
Sep 19, 2014
By BioPharm International Editors
GSK is found guilty of offering bribes to doctors and is fined $489 million.
Sep 17, 2014
By BioPharm International Editors
Baxter announced that its new biopharmaceutical company will be named Baxalta when the company separates into two publicly traded companies in mid-2015.
Sep 09, 2014
By BioPharm International Editors
ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.
Aug 29, 2014
By BioPharm International Editors
Pfizer announced that FDA approved ELELYSO for treatment of Type 1 Gaucher disease in adult and pediatric patients.
Aug 25, 2014
By BioPharm International Editors
PSC Investments announces the acquisition of a high potency, sterile fill/finish pharmaceutical manufacturing facility.
Jul 18, 2014
By BioPharm International Editors
After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.
Jul 18, 2014
By BioPharm International Editors
CPhI 2014 panel additions to provide global insights from the contract services sector.
Jul 09, 2014
By BioPharm International Editors
FDA grants breakthrough therapy designation to Novartis chimeric antigen receptor therapy.
native1_300x100
lorem ipsum